NPC-14 (Arbekacin Sulfate)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NPC-14 (Arbekacin Sulfate), covering 2015-09-03 to 2015-09-03. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of NPC-14 (Arbekacin Sulfate) to Explore Safety, Tolerability, and Efficacy in Duchenne Muscular Dystrophy [Phase 2]